QQ客服 官方微博 反馈留言

	Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
	Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
刊名	Clinical and experimental pharmacology & physiology
	2009
卷号	36期号:3页码:287-296
关键词	Rattus norvegicus Renal receptor for advanced glycation endproducts Angiotensins 血管紧张素类
DOI	10.1111/j.1440-1681.2008.05078.x
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5520483
专题	山东大学
作者单位	Department of Geriatrics, Shandong Provincial Hospital of Shandong University, 324, Jing5-Wei7 Road, 250021, Jinan, Shandong, China, Depar
推荐引用方式 GB/T 7714	Liu XP,Pang YJ,Zhu WW,et al. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.[J]. Clinical and experimental pharmacology & physiology,2009,36(3):287-296.
APA	Liu XP.,Pang YJ.,Zhu WW.,Zhao TT.,Zheng M.,...&Sun SJ.(2009).Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways..Clinical and experimental pharmacology & physiology,36(3),287-296.
MLA	Liu XP,et al."Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.".Clinical and experimental pharmacology & physiology 36.3(2009):287-296.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。